Development of BromoTag: A "Bump-and-Hole"-PROTAC System to Induce Potent, Rapid, and Selective Degradation of Tagged Target Proteins

被引:59
作者
Bond, Adam G. [1 ]
Craigon, Conner [1 ]
Chan, Kwok-Ho [1 ,2 ]
Testa, Andrea [1 ,3 ]
Karapetsas, Athanasios [4 ,5 ]
Fasimoye, Rotimi [4 ]
Macartney, Thomas [4 ]
Blow, J. Julian [6 ]
Alessi, Dario R. [4 ]
Ciulli, Alessio [1 ]
机构
[1] Univ Dundee, Sch Life Sci, Div Biol Chem & Drug Discovery, Dundee DD1 5EH, Scotland
[2] GSK, Gunnels Wood Rd, Stevenage SG1 2NY, Herts, England
[3] Amphista Therapeut Ltd, BioCity, BoNess Rd, Chapelhall ML1 SUH, Motherwell, Scotland
[4] Univ Dundee, Sir James Black Ctr, Sch Life Sci, MRC Prot Phosphorylat & Ubiquitylat Unit, Dundee DD1 5EH, Scotland
[5] AstraZeneca, Hodgkin Bldg B900,Chesterford Res Pk, Cambridge CB10 1XL, England
[6] Univ Dundee, Ctr Gene Regulat & Express, Sch Life Sci, Dundee DD1 5EH, Scotland
基金
欧盟地平线“2020”; 英国惠康基金; 英国医学研究理事会; 欧洲研究理事会;
关键词
E3 UBIQUITIN LIGASE; OPTIMIZATION; INHIBITORS; DISCOVERY;
D O I
10.1021/acs.jmedchem.1c01532
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Small-molecule-induced protein depletion technologies, also called inducible degrons, allow degradation of genetically engineered target proteins within cells and animals. Here, we design and develop the BromoTag, a new inducible degron system comprising a Brd4 bromodomain L387A variant as a degron tag that allows direct recruitment by heterobifunctional bumped proteolysis targeting chimeras (PROTACs) to hijack the VHL E3 ligase. We describe extensive optimization and structure-activity relationships of our bump-and-hole-PROTACs using a CRISPR knock-in cell line expressing model target BromoTagBrd2 at endogenous levels. Collectively, our cellular and mechanistic data qualifies bumped PROTAC AGB1 as a potent, fast, and selective degrader of BromoTagged proteins, with a favorable pharmacokinetic profile in mice. The BromoTag adds to the arsenal of chemical genetic degradation tools allowing us to manipulate protein levels to interrogate the biological function and therapeutic potential in cells and in vivo.
引用
收藏
页码:15477 / 15502
页数:26
相关论文
共 41 条
[1]   Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs [J].
An, Sainan ;
Fu, Liwu .
EBIOMEDICINE, 2018, 36 :553-562
[2]   New Synthetic Routes to Triazolo-benzodiazepine Analogues: Expanding the Scope of the Bump-and-Hole Approach for Selective Bromo and Extra-Terminal (BET) Bromodomain Inhibition [J].
Baud, Matthias G. J. ;
Lin-Shiao, Enrique ;
Zengerle, Michael ;
Tallant, Cynthia ;
Ciulli, Alessio .
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (04) :1492-1500
[3]   A bump-and-hole approach to engineer controlled selectivity of BET bromodomain chemical probes [J].
Baud, Matthias G. J. ;
Lin-Shiao, Enrique ;
Cardote, Teresa ;
Tallant, Cynthia ;
Pschibul, Annica ;
Chan, Kwok-Ho ;
Zengerle, Michael ;
Garcia, Jordi R. ;
Kwan, Terence T. -L. ;
Ferguson, Fleur M. ;
Ciulli, Alessio .
SCIENCE, 2014, 346 (6209) :638-641
[4]   Stereoselective synthesis of allele-specific BET inhibitors [J].
Bond, Adam G. ;
Testa, Andrea ;
Ciulli, Alessio .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2020, 18 (38) :7533-7539
[5]   Proteolysis targeting chimeras (PROTACs) come of age: entering the third decade of targeted protein degradation [J].
Bond, Michael J. ;
Crews, Craig M. .
RSC CHEMICAL BIOLOGY, 2021, 2 (03) :725-742
[6]   HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of Halo Tag Fusion Proteins [J].
Buckley, Dennis L. ;
Raina, Kanak ;
Darricarrere, Nicole ;
Hines, John ;
Gustafson, Jeffrey L. ;
Smith, Ian E. ;
Miah, Aija H. ;
Harling, John D. ;
Crews, Craig M. .
ACS CHEMICAL BIOLOGY, 2015, 10 (08) :1831-1837
[7]   Impact of Target Warhead and Linkage Vector on Inducing Protein Degradation: Comparison of Bromodomain and Extra-Terminal (BET) Degraders Derived from Triazolodiazepine (JQ1) and Tetrahydroquinoline (I-BET726) BET Inhibitor Scaffolds [J].
Chan, Kwok-Ho ;
Zengerle, Michael ;
Testa, Andrea ;
Ciulli, Alessio .
JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (02) :504-513
[8]   Discovery and Characterizatlion of Small Molecule Inhibitors of the BET Family Bromodomains [J].
Chung, Chun-wa ;
Coste, Herve ;
White, Julia H. ;
Mirguet, Olivier ;
Wilde, Jonathan ;
Gosmini, Romain L. ;
Delves, Chris ;
Magny, Sylvie M. ;
Woodward, Robert ;
Hughes, Stephen A. ;
Boursier, Eric V. ;
Flynn, Helen ;
Bouillot, Anne M. ;
Bamborough, Paul ;
Brusq, Jean-Marie G. ;
Gellibert, Francoise J. ;
Jones, Emma J. ;
Riou, Alizon M. ;
Homes, Paul ;
Martin, Sandrine L. ;
Uings, Iain J. ;
Toum, Jerome ;
Clement, Catherine A. ;
Boullay, Anne-Benedicte ;
Grimley, Rachel L. ;
Blande, Florence M. ;
Prinjha, Rab K. ;
Lee, Kevin ;
Kirilovsky, Jorge ;
Nicodeme, Edwige .
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (11) :3827-3838
[9]   A Comprehensive Mathematical Model for Three-Body Binding Equilibria [J].
Douglass, Eugene F., Jr. ;
Miller, Chad J. ;
Sparer, Gerson ;
Shapiro, Harold ;
Spiegel, David A. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2013, 135 (16) :6092-6099
[10]   BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design [J].
Farnaby, William ;
Koegl, Manfred ;
Roy, Michael J. ;
Whitworth, Claire ;
Diers, Emelyne ;
Trainor, Nicole ;
Zollman, David ;
Steurer, Steffen ;
Karolyi-Oezguer, Jale ;
Riedmueller, Carina ;
Gmaschitz, Teresa ;
Wachter, Johannes ;
Dank, Christian ;
Galante, Michael ;
Sharps, Bernadette ;
Rumpel, Klaus ;
Traxler, Elisabeth ;
Gerstberger, Thomas ;
Schnitzer, Renate ;
Petermann, Oliver ;
Grebe, Peter ;
Weinstabl, Harald ;
Bader, Gerd ;
Zoephel, Andreas ;
Weiss-Puxbaum, Alexander ;
Ehrenhoefer-Woelfer, Katharina ;
Woehrle, Simon ;
Boehmelt, Guido ;
Rinnenthal, Joerg ;
Arnhof, Heribert ;
Wiechens, Nicola ;
Wu, Meng-Ying ;
Owen-Hughes, Tom ;
Ettmayer, Peter ;
Pearson, Mark ;
McConnell, Darryl B. ;
Ciulli, Alessio .
NATURE CHEMICAL BIOLOGY, 2019, 15 (07) :672-+